重复肺转移瘤切除术的结局与预后因素
单中心回顾性研究纳入2000至2020年间68例因各类癌症肺转移接受重复肺转移瘤切除术的患者,分析第二次PM的结局与预后因素及第三次PM后的结局。第二次PM后5年无复发生存率和总生存率分别为27%和48%。多变量分析显示首次PM至发现肺转移间隔≤12个月是第二次PM后无复发生存和总生存的不良预后因素。17例接受第三次PM,其中3例获得3年无病生存。
要点
- 第二次PM后5年无复发生存率27%,总生存率48%。
- 首次PM至发现肺转移间隔≤12个月是第二次PM后无复发生存和总生存的不良预后因素。
- 17例接受第三次PM,其中3例获得3年无病生存。
核心结论
- 首次PM至后续发现肺转移间隔>12个月的患者结局较好,被认为是第二次PM的良好候选者。
- 第三次PM可能对部分选择性的患者有益。
研究设计与样本
- 单中心回顾性研究,纳入2000年至2020年间68例因各类癌症肺转移接受重复肺转移瘤切除术的患者。
- 分析第二次PM的结局与预后因素以及第三次PM后的结局。
主要发现
- 纳入39例男性和29例女性,第二次PM时平均年龄53.2岁。
- 原发肿瘤为软组织肉瘤24例、结直肠癌19例、骨肉瘤10例。
- 首次PM至首次PM后发现肺转移的间隔≤12个月者37例,>12个月者31例。
- 第二次PM时20例接受肺叶或双肺叶切除,48例接受亚肺叶切除;60例实现完全切除,52例在第二次PM后出现复发。
- 第二次PM后5年无复发生存率和总生存率分别为27%和48%;多变量分析显示首次PM至后续发现肺转移间隔≤12个月是第二次PM后无复发生存和总生存的不良预后因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Information on prognostic factors after repeat pulmonary metastasectomy (PM) is limited, and outcomes after a third PM are not well documented. METHODS: A single-institute retrospective study was conducted. Between 2000 and 2020, 68 patients underwent repeat PM for pulmonary metastases from various cancers. Outcomes and prognostic factors for the second PM and outcomes after the third PM were analysed. RESULTS: This study included 39 men and 29 women. The mean age at second PM was 53.2 years old. The primary tumours were soft tissue sarcoma in 24 patients, colorectal cancer in 19 and osteosarcoma in 10. The interval between the first PM procedure and detection of pulmonary metastasis after the first PM (months) was ≤12 in 37 patients and >12 in 31 patients. At the second PM, 20 patients underwent lobectomy or bilobectomy, and 48 underwent sublobar resection. Complete resection was achieved in 60 patients, and 52 patients experienced recurrence after the second PM. The 5-year relapse-free survival and overall survival rates after the second PM were 27% and 48%, respectively. Multivariable analysis revealed that the interval between the first PM and the subsequent detection of pulmonary metastasis (≤12 months) was a poor prognostic factor for both relapse-free survival and overall survival after the second PM. Seventeen patients underwent a third PM, 3 of whom achieved a 3-year disease-free survival. CONCLUSIONS: Patients with a period of >12 months between the first PM and the subsequent detection of pulmonary metastases showed favourable outcomes and are thus considered good candidates for second PM. A third PM may be beneficial for selected patients.
引用
- Kanzaki R, Watari H, Omura A, et al. Outcomes and prognostic factors of repeat pulmonary metastasectomy. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 38426364. doi:10.1093/icvts/ivae028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。